Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study（TOPS-CSVD）
PHASE4Not yet recruitingINTERVENTIONAL
Enrollment
1,052
Participants
Timeline
Start Date
October 31, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Conditions
Cerebral Small Vessel Diseases
Interventions
DRUG
Tongxinluo Capsule
4 capsules/time, tid, p.o Duration of Treatment: 1 year (12 months)